The molecular mechanism in pancreatic β cells underlying
hyperlipidemia and
insulin insufficiency remains unclear. Here, we find that the
fatty acid-induced decrease in
insulin levels occurs due to a decrease in
insulin translation. Since regulation at the translational level is generally mediated through
RNA-binding proteins, using
RNA antisense purification coupled with mass spectrometry, we identify a novel
insulin mRNA-
binding protein, namely, DDX1, that is sensitive to
palmitate treatment. Notably, the knockdown or overexpression of DDX1 affects
insulin translation, and the knockdown of DDX1 eliminates the
palmitate-induced repression of
insulin translation. Molecular mechanism studies show that
palmitate treatment causes DDX1 phosphorylation at S295 and dissociates DDX1 from
insulin mRNA, thereby leading to the suppression of
insulin translation. In addition, DDX1 may interact with the translation
initiation factors eIF3A and
eIF4B to regulate translation. In high-fat diet mice, the inhibition of
insulin translation happens at an early prediabetic stage before the elevation of
glucose levels. We speculate that the DDX1-mediated repression of
insulin translation worsens the situation of
insulin resistance and contributes to the elevation of
blood glucose levels in obese animals.